D.A. Davidson & CO. Decreases Stake in Solventum Co. (NYSE:SOLV)

D.A. Davidson & CO. lowered its stake in Solventum Co. (NYSE:SOLV) by 2.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,480 shares of the company’s stock after selling 185 shares during the quarter. D.A. Davidson & CO.’s holdings in Solventum were worth $560,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently modified their holdings of the business. Hotchkis & Wiley Capital Management LLC purchased a new position in Solventum in the 3rd quarter worth approximately $125,488,000. Trian Fund Management L.P. increased its stake in Solventum by 32.9% in the 3rd quarter. Trian Fund Management L.P. now owns 7,126,255 shares of the company’s stock worth $496,842,000 after purchasing an additional 1,765,676 shares during the period. Point72 Asset Management L.P. purchased a new position in shares of Solventum during the third quarter valued at approximately $50,948,000. Nordea Investment Management AB increased its stake in shares of Solventum by 189.5% during the fourth quarter. Nordea Investment Management AB now owns 659,887 shares of the company’s stock valued at $43,902,000 after buying an additional 431,986 shares during the period. Finally, General American Investors Co. Inc. purchased a new position in shares of Solventum during the third quarter valued at approximately $14,456,000.

Analyst Ratings Changes

SOLV has been the topic of several recent research reports. Piper Sandler upped their price target on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research note on Friday, November 8th. Mizuho initiated coverage on Solventum in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 price target on the stock. Finally, Morgan Stanley upped their price target on Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research note on Monday, November 11th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $68.29.

Solventum Stock Up 9.8 %

SOLV opened at $83.74 on Wednesday. The stock’s fifty day moving average is $71.58 and its two-hundred day moving average is $69.53. Solventum Co. has a 52 week low of $47.16 and a 52 week high of $96.05. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.